https://www.selleckchem.com/pr....oducts/cerdulatinib-
sit does not affect pregnancy outcomes. This observation remains true for patients who are in the high-risk categories for poor response to ovarian stimulation. Providers and patients should be reassured that when a short-term treatment delay is deemed necessary for medical, logistic or financial reasons, treatment outcomes will not be affected. Study funding/competing interest(s) No financial support, funding or services were obtained for this study. The authors do not report any potential conflicts of interest.
Like
Comment
Share
